Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Research Article

Comparison of Amiodarone Loading Dosage in the Treatment of Postoperative Atrial Fibrillation: High Versus Standard Dose Treatment

Author(s): Ersin Sarıçam, Arslan Öcal, Murat Doğan Iscanlı, Engin Bozkurt, Erdogan Ilkay and Ömer Faruk Cantekin*

Volume 22, Issue 6, 2024

Published on: 29 August, 2024

Page: [386 - 390] Pages: 5

DOI: 10.2174/0115701611259127231208051249

Price: $65

TIMBC 2025
Abstract

Background: Postoperative atrial fibrillation (POAF) is associated with poor outcomes, including hemodynamic instability, stroke, myocardial infarction, and death. In hemodynamic stable patients, the rhythm-control strategy is more advantageous than rate control. Current standard intravenous amiodarone administration has limited success and a delayed effect; the acute success rate is 44% (8-12 h to several days).

Purpose: The aim of this study was to evaluate the effectiveness of higher amiodarone loading dosage to restore sinus rhythm in patients with POAF after noncardiac surgery.

Methods: This is a prospective, randomized, controlled single-center study. The study included 39 patients with POAF, divided into group I (n=27) (intravenous 600 mg amiodarone loading dosage over 2 h and infusion of 50 mg/h over a 24-h period) and group II (n=12) (standard protocol; 300 mg of bolus intravenously in 30 min and infusion of 50 mg/h over a 24-h period). The primary endpoint of the study was a restoration of sinus rhythm at the 24th hour.

Results: Baseline clinical, laboratory and echocardiographic characteristics of both groups were similar. The patients with higher loading amiodarone dosage had earlier restoration of sinus rhythm (2.38 ± 1.41 vs 8.66 ± 2.87 h, respectively; p=0.015). There was no significant difference in achieving sinus rhythm at the 24th hour between both groups.

Conclusion: Higher loading amiodarone dosage increased early conversions to sinus rhythm compared with standard amiodarone protocol in patients with POAF.

Keywords: Amiodarone, dosage, postoperative atrial fibrillation, sinus rhythm, laboratory, echocardiographic.

Graphical Abstract
[1]
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021; 42(5): 373-498.
[http://dx.doi.org/10.1093/eurheartj/ehaa612] [PMID: 32860505]
[2]
Conen D, Alonso-Coello P, Douketis J, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J 2020; 41(5): 645-51.
[http://dx.doi.org/10.1093/eurheartj/ehz431] [PMID: 31237939]
[3]
AlTurki A, Marafi M, Proietti R, et al. Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2020; 13(1): e007437.
[http://dx.doi.org/10.1161/CIRCEP.119.007437] [PMID: 31944855]
[4]
Gillinov AM, Bagiella E, Moskowitz AJ, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 2016; 374(20): 1911-21.
[http://dx.doi.org/10.1056/NEJMoa1602002] [PMID: 27043047]
[5]
Karamnov S, Muehlschlegel JD. Inflammatory responses to surgery and postoperative atrial fibrillation. Anesthesiology 2022; 136(6): 877-9.
[http://dx.doi.org/10.1097/ALN.0000000000004233] [PMID: 35482968]
[6]
Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: An overview. J Thromb Haemost 2015; 13 (Suppl. 1): S304-12.
[http://dx.doi.org/10.1111/jth.12974] [PMID: 26149040]
[7]
Albini A, Malavasi VL, Vitolo M, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis. Eur J Intern Med 2021; 85: 27-33.
[http://dx.doi.org/10.1016/j.ejim.2020.12.018] [PMID: 33402281]
[8]
Lin MH, Kamel H, Singer DE, Wu YL, Lee M, Ovbiagele B. Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke 2019; 50(6): 1364-71.
[http://dx.doi.org/10.1161/STROKEAHA.118.023921] [PMID: 31043148]
[9]
Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022; 43(39): 3826-924.
[http://dx.doi.org/10.1093/eurheartj/ehac270] [PMID: 36017553]
[10]
Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P. Amiodarone versus placebo and class ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41(2): 255-62.
[http://dx.doi.org/10.1016/S0735-1097(02)02705-5] [PMID: 12535819]
[11]
Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study. J Am Coll Cardiol 1996; 27(5): 1079-82.
[http://dx.doi.org/10.1016/0735-1097(95)00595-1] [PMID: 8609324]
[12]
Martínez-Marcos FJ, García-Garmendia JL, Ortega-Carpio A, Fernández-Gómez JM, Santos JM, Camacho C. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 2000; 86(9): 950-3.
[http://dx.doi.org/10.1016/S0002-9149(00)01128-0] [PMID: 11053705]
[13]
Gaudino M, Di Franco A, Rong LQ, Piccini J, Mack M. Postoperative atrial fibrillation: From mechanisms to treatment. Eur Heart J 2023; 44(12): 1020-39.
[http://dx.doi.org/10.1093/eurheartj/ehad019] [PMID: 36721960]
[14]
Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: Mechanisms, manifestations and management. Nat Rev Cardiol 2019; 16(7): 417-36.
[http://dx.doi.org/10.1038/s41569-019-0166-5] [PMID: 30792496]
[15]
Ducas R, Ariyarajah V. Atrial fibrillation in patients with ischemic and non-ischemic left ventricular dysfunction. J Atr Fibrillation 2013; 5(5): 535.
[PMID: 28496804]
[16]
Kochiadakis G, Skalidis EI, Kalebubas MD, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J 2002; 23(9): 734-41.
[http://dx.doi.org/10.1053/euhj.2001.2894] [PMID: 11978000]
[17]
Heintz KM, Hollenberg SM. Perioperative cardiac issues: Postoperative arrhythmias. Surg Clin North Am 2005; 85(6) 1103-1114 [viii].
[http://dx.doi.org/10.1016/j.suc.2005.09.003] [PMID: 16326196]
[18]
Cotter G, Blatt A, Kaluski E, et al. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. Eur Heart J 1999; 20(24): 1833-42.
[http://dx.doi.org/10.1053/euhj.1999.1747] [PMID: 10581142]
[19]
Donovan KD, Power BM, Hockings BEF, Dobb GJ, Lee K-Y. Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillation. Am J Cardiol 1995; 75(10): 693-7.
[http://dx.doi.org/10.1016/S0002-9149(99)80655-9] [PMID: 7900662]
[20]
Tuseth V, Jaatun HJ, Dickstein K. Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment. Heart 2005; 91(7): 964-5.
[http://dx.doi.org/10.1136/hrt.2004.049171] [PMID: 15958375]
[21]
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2019; 74(1): 104-32.
[http://dx.doi.org/10.1016/j.jacc.2019.01.011] [PMID: 30703431]
[22]
Karacaglar E, Atar I, Ozbiçer S, et al. Amiodarone versus direct current cardioversion in treatment of atrial fibrillation after cardiac surgery. Turk J Clin Lab 2019; (10): 26-32. [Available from https://dergipark.org.tr/en/pub/tjcl/issue/44073/519537

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy